fda tirzepatide news FDA's decision creates uncertainty for patients—and leads to a lawsuit FDA restricts non-approved compounded GLP-1

Ideal candidates are those with a high BMI, weight-related health issues, and a commitment to lifestyle changes

The result is a next-generation oral complexdesigned to provide predictable, targeted support for those seeking to promote recovery, cellular resilience, and gastrointestinal wellness as part of their longevity regimen

Retatrutide is not FDA approved, isnt legally available by prescription, and may cause stronger side effects at higher doses

Trade Representative, the Commerce Department and the White House, including serving as Deputy U.S

Any manufacturing problem or the loss of a contract manufacturer could be disruptive to our operations and result in lost sales